Physician profile
Amy A Isabelle
NPI 1568084093
$2,972.47
in general payments reported to CMS, 2019-2025
16 companies · $1,697 in 2025
The $1,697 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $115 · 2023: $455 · 2024: $705 · 2025: $1,697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,857.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $601.07 | 2023-2025 | |
| Gilead Sciences, INC. | $547.35 | 2022-2025 | Epclusa, Biktarvy |
| Merck Sharp & Dohme LLC | $329.84 | 2022-2025 | Pifeltro, Delstrigo, Capvaxive |
| Viiv Healthcare Company | $286.76 | 2025 | Dovato, Apretude, Cabenuva |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $266.69 | 2022-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $234.38 | 2022-2025 | Ingrezza |
| Janssen Pharmaceuticals, INC | $182.23 | 2025 | Invega Sustenna |
| Alkermes, INC. | $152.41 | 2022-2025 | Vivitrol |
| Astrazeneca Pharmaceuticals LP | $96.72 | 2024 | Tezspire |
| Exact Sciences Corporation | $93.52 | 2024-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $37.11 | 2024-2025 | Arexvy, Shingrix, Bexsero |
| Braeburn INC. | $36.68 | 2025 | Brixadi |
| Novo Nordisk INC | $36.62 | 2023 | Rybelsus, Ozempic |
| Indivior INC. | $31.67 | 2024 | Sublocade |
| Paratek Pharmaceuticals, INC. | $20.35 | 2025 | Nuzyra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $19.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Isabelle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.